Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Clinical trial NCT03709550 · WITHDRAWN

Trial details

NCT number: NCT03709550
Sponsor: Roswell Park Cancer Institute
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Castration Levels of Testosterone Castration-Resistant Prostate Carcinoma Metastatic Prostate Carcinoma in the Soft Tissue Prostate Carcinoma Metastatic in the Bone PSA Level Greater Than or Equal to Two PSA Progression Stage IV Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8

Start date: 2021-04-15
Primary completion: 2023-04-15
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.